Trials / Completed
CompletedNCT04114669
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
Behavioral Economics Trial To Enhance Regulation of Blood Pressure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H ambulatory clinics as well as NYU Langone Family Health Centers, and will use a lottery incentive program to promote adherence to antihypertensive medication that will be delivered via smartphone for 6 months. The trial will randomize 435 patients with hypertension determined to have poor adherence (\<80% adherence with antihypertensive medication), in a 2:1 (intervention:control) ratio. Baseline enrollment will occur over 36 months with an expected 12 months follow-up per participant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Control Condition | 3 in-person study visits, approximately one hour each. These will take place at baseline, 6 months, and 12 months. |
| BEHAVIORAL | Regret Lottery | Delivered by the Way to Health platform, installed on a smartphone and communicates with participants via text message.Participants are eligible to receive a potential cash reward if they are adherent with their antihypertensive medication the day before, which is monitored via electronic monitoring device (EMD) from AdhereTech. Each participant is assigned a 2-digit number for the trial, and each day the Way to Health platform randomly generates a 2-digit number. Participants will receive a prize if both digits match (1 in 100 chance) and will receive a prize of lesser value if one digit matches (18 in 100 chance). If they are not adherent with their medication, but would have won if they were adherent, they receive a text message that they would have won ("regret" component). |
Timeline
- Start date
- 2020-07-14
- Primary completion
- 2025-05-12
- Completion
- 2025-09-12
- First posted
- 2019-10-03
- Last updated
- 2025-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04114669. Inclusion in this directory is not an endorsement.